P366: ARE MINIMAL RESIDUAL DISEASE MEASUREMENTS AFTER CONSOLIDATION THERAPY USEFUL IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA? by Janine Stutterheim, Rachella Van der Waarden, Hester de Groot-Kruseman, Edwin Sonneveld, Valerie De Haas, Ellen C Van der Schoot, Vincent van der Velden, Rana Dandis, Rob Pieters

Get full text

Definitions matter: Multicenter investigation of incidence and outcome of poor graft function after hematopoietic cell transplantation by Konradin F. Müskens, Winny N. R. Collot‐d'Escury, Rana Dandis, Saskia Haitjema, Jürgen Kuball, Moniek A. deWitte, Marc Bierings, Caroline A. Lindemans, Stefan Nierkens, Mirjam E. Belderbos

Get full text

The Prognostic Value of Eight Immunohistochemical Markers Expressed in the Tumor Microenvironment and on Hodgkin Reed-Sternberg Cells in Pediatric Patients With Classical Hodgkin L... by Eline A. M. Zijtregtop, Eline A. M. Zijtregtop, Ilse Tromp, Rana Dandis, Christian M. Zwaan, Christian M. Zwaan, King H. Lam, Friederike A. G. Meyer-Wentrup, Auke Beishuizen, Auke Beishuizen

Get full text

Impact of the COVID‐19 pandemic on paediatric renal tumour presentation and management, a SIOP renal tumour study group study by Prakriti Roy, Sophie E. vanPeer, Rana Dandis, Catriona Duncan, Joaquim Caetano deAguirre‐Neto, Arnauld Verschuur, Beatriz deCamargo, Henrike E. Karim‐Kos, Luna Boschetti, Filippo Spreafico, Gema L. Ramirez‐Villar, Norbert Graf, Harm vanTinteren, Kathy Pritchard‐Jones, Marry M. van denHeuvel‐Eibrink

Get full text

MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma by Thomas F. Eleveld, Thomas F. Eleveld, Lindy Vernooij, Linda Schild, Bianca Koopmans, Lindy K. Alles, Marli E. Ebus, Rana Dandis, Harm van Tinteren, Huib N. Caron, Jan Koster, Max M. van Noesel, Godelieve A. M. Tytgat, Selma Eising, Rogier Versteeg, M. Emmy M. Dolman, M. Emmy M. Dolman, M. Emmy M. Dolman, Jan J. Molenaar, Jan J. Molenaar

Get full text